Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.
Identifieur interne : 001186 ( PubMed/Checkpoint ); précédent : 001185; suivant : 001187Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.
Auteurs : Betty Smoot [États-Unis] ; Sarah Zerzan ; Joanne Krasnoff ; Josephine Wong ; Maria Cho ; Marylin DoddSource :
- Breast cancer research and treatment [ 1573-7217 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Association thérapeutique, Exercice physique, Femelle, Humains, Impédance électrique, Lymphoedème (diagnostic), Lymphoedème (étiologie), Membre supérieur (anatomopathologie), Pronostic, Stade de la tumeur, Survivants, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (rééducation et réadaptation), Épreuve d'effort, Études de suivi, Études transversales.
- MESH :
- anatomopathologie : Membre supérieur, Tumeurs du sein.
- diagnostic : Lymphoedème.
- rééducation et réadaptation : Tumeurs du sein.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Association thérapeutique, Exercice physique, Femelle, Humains, Impédance électrique, Pronostic, Stade de la tumeur, Survivants, Tumeurs du sein, Épreuve d'effort, Études de suivi, Études transversales.
English descriptors
- KwdEn :
- Breast Neoplasms (complications), Breast Neoplasms (pathology), Breast Neoplasms (rehabilitation), Breast Neoplasms (therapy), Combined Modality Therapy, Cross-Sectional Studies, Electric Impedance, Exercise, Exercise Test, Female, Follow-Up Studies, Humans, Lymphedema (diagnosis), Lymphedema (etiology), Middle Aged, Neoplasm Staging, Prognosis, Survivors, Upper Extremity (pathology).
- MESH :
- complications : Breast Neoplasms.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- pathology : Breast Neoplasms, Upper Extremity.
- rehabilitation : Breast Neoplasms.
- therapy : Breast Neoplasms.
- Combined Modality Therapy, Cross-Sectional Studies, Electric Impedance, Exercise, Exercise Test, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Prognosis, Survivors.
Abstract
Research on the effect of cardiorespiratory (CR) exercise on upper extremity (UE) limb volume is limited in women with breast cancer-related lymphedema (BCRL). The aim of this study was to compare changes in UE volume immediately following a symptom-limited CR treadmill test in women with and without BCRL. As part of a cross-sectional study, 133 women post unilateral BC treatment completed symptom-limited treadmill testing. Bioimpedance spectroscopy (BIS) was used to measure UE resistance before and immediately following treadmill testing. Resistance ratios >1 (unaffected side/affected side) indicate greater volume in the affected limb. T-tests and repeated measures ANOVA were performed to evaluate differences between and within groups. Mean age was 56.2 years (SD 9.4); BMI was 26.13 kg m(-2) (SD 5.04). For women with previously diagnosed BCRL (n = 63), the resistance ratio was 1.116 (SD 0.160) pre-treadmill and 1.108 (SD 0.155) post-treadmill. For women without BCRL (n = 70), the resistance ratio was 0.990 (SD 0.041) pre-treadmill and 1.001 (SD 0.044) post-treadmill. Resistance ratios for women with BCRL were higher than those for women without BCRL at both time points (main effect of group: p < 0.001). No main effects were found for time (p = 0.695). A statistically significant effect was found for the time-by-group interaction (p = 0.002). 78% of the women with BCRL wore a compression garment during testing. Following testing, the women with BCRL demonstrated a non-statistically significant decrease in the resistance ratio, suggesting an immediate decrease in interlimb volume difference. The women without BCRL demonstrated an increase in the resistance ratio.
DOI: 10.1007/s10549-014-3171-8
PubMed: 25338320
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25338320Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.</title><author><name sortKey="Smoot, Betty" sort="Smoot, Betty" uniqKey="Smoot B" first="Betty" last="Smoot">Betty Smoot</name><affiliation wicri:level="1"><nlm:affiliation>Department of Physical Therapy and Rehabilitation Science, Graduate Program in Physical Therapy, University of California, San Francisco State University, Box 0736, San Francisco, CA, 94143, USA, betty.smoot@ucsf.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Physical Therapy and Rehabilitation Science, Graduate Program in Physical Therapy, University of California, San Francisco State University, Box 0736, San Francisco, CA, 94143, USA</wicri:regionArea><wicri:noRegion>USA</wicri:noRegion></affiliation></author><author><name sortKey="Zerzan, Sarah" sort="Zerzan, Sarah" uniqKey="Zerzan S" first="Sarah" last="Zerzan">Sarah Zerzan</name></author><author><name sortKey="Krasnoff, Joanne" sort="Krasnoff, Joanne" uniqKey="Krasnoff J" first="Joanne" last="Krasnoff">Joanne Krasnoff</name></author><author><name sortKey="Wong, Josephine" sort="Wong, Josephine" uniqKey="Wong J" first="Josephine" last="Wong">Josephine Wong</name></author><author><name sortKey="Cho, Maria" sort="Cho, Maria" uniqKey="Cho M" first="Maria" last="Cho">Maria Cho</name></author><author><name sortKey="Dodd, Marylin" sort="Dodd, Marylin" uniqKey="Dodd M" first="Marylin" last="Dodd">Marylin Dodd</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25338320</idno><idno type="pmid">25338320</idno><idno type="doi">10.1007/s10549-014-3171-8</idno><idno type="wicri:Area/PubMed/Corpus">001240</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001240</idno><idno type="wicri:Area/PubMed/Curation">001240</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001240</idno><idno type="wicri:Area/PubMed/Checkpoint">001240</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001240</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.</title><author><name sortKey="Smoot, Betty" sort="Smoot, Betty" uniqKey="Smoot B" first="Betty" last="Smoot">Betty Smoot</name><affiliation wicri:level="1"><nlm:affiliation>Department of Physical Therapy and Rehabilitation Science, Graduate Program in Physical Therapy, University of California, San Francisco State University, Box 0736, San Francisco, CA, 94143, USA, betty.smoot@ucsf.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Physical Therapy and Rehabilitation Science, Graduate Program in Physical Therapy, University of California, San Francisco State University, Box 0736, San Francisco, CA, 94143, USA</wicri:regionArea><wicri:noRegion>USA</wicri:noRegion></affiliation></author><author><name sortKey="Zerzan, Sarah" sort="Zerzan, Sarah" uniqKey="Zerzan S" first="Sarah" last="Zerzan">Sarah Zerzan</name></author><author><name sortKey="Krasnoff, Joanne" sort="Krasnoff, Joanne" uniqKey="Krasnoff J" first="Joanne" last="Krasnoff">Joanne Krasnoff</name></author><author><name sortKey="Wong, Josephine" sort="Wong, Josephine" uniqKey="Wong J" first="Josephine" last="Wong">Josephine Wong</name></author><author><name sortKey="Cho, Maria" sort="Cho, Maria" uniqKey="Cho M" first="Maria" last="Cho">Maria Cho</name></author><author><name sortKey="Dodd, Marylin" sort="Dodd, Marylin" uniqKey="Dodd M" first="Marylin" last="Dodd">Marylin Dodd</name></author></analytic><series><title level="j">Breast cancer research and treatment</title><idno type="eISSN">1573-7217</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (rehabilitation)</term><term>Breast Neoplasms (therapy)</term><term>Combined Modality Therapy</term><term>Cross-Sectional Studies</term><term>Electric Impedance</term><term>Exercise</term><term>Exercise Test</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Survivors</term><term>Upper Extremity (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Exercice physique</term><term>Femelle</term><term>Humains</term><term>Impédance électrique</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Membre supérieur (anatomopathologie)</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Survivants</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (rééducation et réadaptation)</term><term>Épreuve d'effort</term><term>Études de suivi</term><term>Études transversales</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Membre supérieur</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term><term>Cross-Sectional Studies</term><term>Electric Impedance</term><term>Exercise</term><term>Exercise Test</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Exercice physique</term><term>Femelle</term><term>Humains</term><term>Impédance électrique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Survivants</term><term>Tumeurs du sein</term><term>Épreuve d'effort</term><term>Études de suivi</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Research on the effect of cardiorespiratory (CR) exercise on upper extremity (UE) limb volume is limited in women with breast cancer-related lymphedema (BCRL). The aim of this study was to compare changes in UE volume immediately following a symptom-limited CR treadmill test in women with and without BCRL. As part of a cross-sectional study, 133 women post unilateral BC treatment completed symptom-limited treadmill testing. Bioimpedance spectroscopy (BIS) was used to measure UE resistance before and immediately following treadmill testing. Resistance ratios >1 (unaffected side/affected side) indicate greater volume in the affected limb. T-tests and repeated measures ANOVA were performed to evaluate differences between and within groups. Mean age was 56.2 years (SD 9.4); BMI was 26.13 kg m(-2) (SD 5.04). For women with previously diagnosed BCRL (n = 63), the resistance ratio was 1.116 (SD 0.160) pre-treadmill and 1.108 (SD 0.155) post-treadmill. For women without BCRL (n = 70), the resistance ratio was 0.990 (SD 0.041) pre-treadmill and 1.001 (SD 0.044) post-treadmill. Resistance ratios for women with BCRL were higher than those for women without BCRL at both time points (main effect of group: p < 0.001). No main effects were found for time (p = 0.695). A statistically significant effect was found for the time-by-group interaction (p = 0.002). 78% of the women with BCRL wore a compression garment during testing. Following testing, the women with BCRL demonstrated a non-statistically significant decrease in the resistance ratio, suggesting an immediate decrease in interlimb volume difference. The women without BCRL demonstrated an increase in the resistance ratio.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25338320</PMID><DateCreated><Year>2014</Year><Month>11</Month><Day>07</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7217</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Breast cancer research and treatment</Title><ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation></Journal><ArticleTitle>Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.</ArticleTitle><Pagination><MedlinePgn>445-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-014-3171-8</ELocationID><Abstract><AbstractText>Research on the effect of cardiorespiratory (CR) exercise on upper extremity (UE) limb volume is limited in women with breast cancer-related lymphedema (BCRL). The aim of this study was to compare changes in UE volume immediately following a symptom-limited CR treadmill test in women with and without BCRL. As part of a cross-sectional study, 133 women post unilateral BC treatment completed symptom-limited treadmill testing. Bioimpedance spectroscopy (BIS) was used to measure UE resistance before and immediately following treadmill testing. Resistance ratios >1 (unaffected side/affected side) indicate greater volume in the affected limb. T-tests and repeated measures ANOVA were performed to evaluate differences between and within groups. Mean age was 56.2 years (SD 9.4); BMI was 26.13 kg m(-2) (SD 5.04). For women with previously diagnosed BCRL (n = 63), the resistance ratio was 1.116 (SD 0.160) pre-treadmill and 1.108 (SD 0.155) post-treadmill. For women without BCRL (n = 70), the resistance ratio was 0.990 (SD 0.041) pre-treadmill and 1.001 (SD 0.044) post-treadmill. Resistance ratios for women with BCRL were higher than those for women without BCRL at both time points (main effect of group: p < 0.001). No main effects were found for time (p = 0.695). A statistically significant effect was found for the time-by-group interaction (p = 0.002). 78% of the women with BCRL wore a compression garment during testing. Following testing, the women with BCRL demonstrated a non-statistically significant decrease in the resistance ratio, suggesting an immediate decrease in interlimb volume difference. The women without BCRL demonstrated an increase in the resistance ratio.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smoot</LastName><ForeName>Betty</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy and Rehabilitation Science, Graduate Program in Physical Therapy, University of California, San Francisco State University, Box 0736, San Francisco, CA, 94143, USA, betty.smoot@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zerzan</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Krasnoff</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Josephine</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dodd</LastName><ForeName>Marylin</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12HD052163</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR000143</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NR010282</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R21 NR0101282U</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024131</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2TR000143</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 HD052163</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000004</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Breast Cancer Res Treat</MedlineTA><NlmUniqueID>8111104</NlmUniqueID><ISSNLinking>0167-6806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Rehabil Med. 2008 Aug;40(8):651-8</RefSource><PMID Version="1">19020699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource><PMID Version="1">16379589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiother Theory Pract. 2009 Apr;25(3):165-73</RefSource><PMID Version="1">19384736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Biomed Eng. 1986;14(1):45-91</RefSource><PMID Version="1">3524994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource><PMID Version="1">23540561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 2007 May;58(5):541-3</RefSource><PMID Version="1">17452840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2001 Mar;34(1):2-11</RefSource><PMID Version="1">11307661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiother Theory Pract. 2014 May;30(4):236-42</RefSource><PMID Version="1">24175620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jun;133(2):667-76</RefSource><PMID Version="1">22286332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Oct 1;25(28):4396-404</RefSource><PMID Version="1">17785708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource><PMID Version="1">19675330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Dec 22;304(24):2699-705</RefSource><PMID Version="1">21148134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Integr Cancer Ther. 2013 Sep;12(5):423-32</RefSource><PMID Version="1">23439658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Clin Oncol. 2014 May 10;5(2):177-90</RefSource><PMID Version="1">24829866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rehabil Oncol. 2008 Apr 1;26(2):20-31</RefSource><PMID Version="1">20664723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2006 Jul 4;175(1):34-41</RefSource><PMID Version="1">16818906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Clin Oncol. 2012 May;1(1):21-31</RefSource><PMID Version="1">24058390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2005 Nov;13(11):904-11</RefSource><PMID Version="1">15812652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Oct 15;20(20):4242-8</RefSource><PMID Version="1">12377968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Feb;89(3):221-6</RefSource><PMID Version="1">15754119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiol Clin. 1993 May;11(2):199-213</RefSource><PMID Version="1">8508447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2000 May;904:571-5</RefSource><PMID Version="1">10865807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2004 Sep;36(9):1484-91</RefSource><PMID Version="1">15354027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Apr 15;118(8 Suppl):2312-24</RefSource><PMID Version="1">22488705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):28-40</RefSource><PMID Version="1">23375064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2010 Jun;4(2):167-78</RefSource><PMID Version="1">20373044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2009;48(8):1102-10</RefSource><PMID Version="1">19863217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2010 Jul;42(7):1409-26</RefSource><PMID Version="1">20559064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Dec;5(4):320-36</RefSource><PMID Version="1">22002586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2009 Mar;41(3):483-9</RefSource><PMID Version="1">19204604</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="Y">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="Y">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS641655</OtherID><OtherID Source="NLM">PMC4243702</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25338320</ArticleId><ArticleId IdType="doi">10.1007/s10549-014-3171-8</ArticleId><ArticleId IdType="pmc">PMC4243702</ArticleId><ArticleId IdType="mid">NIHMS641655</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Cho, Maria" sort="Cho, Maria" uniqKey="Cho M" first="Maria" last="Cho">Maria Cho</name><name sortKey="Dodd, Marylin" sort="Dodd, Marylin" uniqKey="Dodd M" first="Marylin" last="Dodd">Marylin Dodd</name><name sortKey="Krasnoff, Joanne" sort="Krasnoff, Joanne" uniqKey="Krasnoff J" first="Joanne" last="Krasnoff">Joanne Krasnoff</name><name sortKey="Wong, Josephine" sort="Wong, Josephine" uniqKey="Wong J" first="Josephine" last="Wong">Josephine Wong</name><name sortKey="Zerzan, Sarah" sort="Zerzan, Sarah" uniqKey="Zerzan S" first="Sarah" last="Zerzan">Sarah Zerzan</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Smoot, Betty" sort="Smoot, Betty" uniqKey="Smoot B" first="Betty" last="Smoot">Betty Smoot</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001186 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001186 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25338320
|texte= Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25338320" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |